Sijia Yu Selected Research

Sijia Yu Research Topics

Disease

5	Neoplasms (Cancer) 01/2024 - 01/2020
5	Chronic Renal Insufficiency 01/2023 - 01/2021
4	Heart Failure 08/2023 - 01/2021
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 01/2021
3	Inflammation (Inflammations) 03/2024 - 12/2022
3	Obesity 05/2023 - 01/2022
2	Myocardial Infarction 03/2024 - 01/2021
2	Tuberculosis (Tuberculoses) 11/2023 - 01/2023
2	Acute Kidney Injury (Acute Renal Failure) 11/2023 - 07/2023
2	Breast Neoplasms (Breast Cancer) 08/2023 - 01/2020
2	Hypertension (High Blood Pressure) 01/2022 - 01/2021
2	Atrial Fibrillation 01/2022 - 01/2021
1	Atherosclerosis 03/2024
1	Atherosclerotic Plaque (Atheroma) 03/2024
1	Colonic Neoplasms (Colon Cancer) 01/2024
1	Type 2 Diabetes Mellitus (MODY) 11/2023
1	Kidney Diseases (Kidney Disease) 08/2023
1	Myocardial Ischemia (Ischemic Heart Diseases) 07/2023
1	Body Weight (Weight, Body) 05/2023
1	Major Depressive Disorder (Major Depressive Disorders) 01/2023
1	Malnutrition (Nutritional Deficiencies) 01/2022
1	Diabetes Mellitus 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Diabetes Complications 01/2022
1	Neoplasm Metastasis (Metastasis) 12/2021
1	Hypersensitivity (Allergy) 12/2021
1	Stroke (Strokes) 01/2021
1	Esophageal Neoplasms (Esophageal Cancer) 01/2021
1	Anemia 01/2021
1	Poisoning 02/2018
1	Cholangiocarcinoma 01/2018

Drug/Important Bio-Agent (IBA)

2	HDL CholesterolIBA 03/2024 - 01/2021
2	Rifampin (Rifampicin)FDA LinkGeneric 11/2023 - 01/2023
2	RNA (Ribonucleic Acid)IBA 12/2022 - 01/2022
2	LipidsIBA 12/2022 - 01/2022
2	oxidized low density lipoproteinIBA 01/2022 - 01/2021
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 01/2021
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2021
2	LDL CholesterolIBA 01/2022 - 01/2021
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2020
1	HDL LipoproteinsIBA 03/2024
1	Fibrinogen (Factor I)FDA Link 03/2024
1	Decitabine FDA Link 01/2024
1	Cyclin-Dependent Kinase 9IBA 01/2024
1	ChromatinIBA 01/2024
1	Biomarkers (Surrogate Marker)IBA 11/2023
1	giredestrantIBA 08/2023
1	pro-brain natriuretic peptide (1-76)IBA 08/2023
1	Estrogen ReceptorsIBA 08/2023
1	Brain Natriuretic Peptide (Natrecor)FDA Link 08/2023
1	Estrogen Receptor AntagonistsIBA 08/2023
1	Contrast MediaIBA 07/2023
1	Immunoglobulin G (IgG)IBA 05/2023
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2023
1	Hemoglobins (Hemoglobin)IBA 01/2023
1	Escitalopram FDA Link 01/2023
1	Lipoproteins (Lipoprotein)IBA 12/2022
1	Protein Isoforms (Isoforms)IBA 12/2022
1	OligonucleotidesIBA 12/2022
1	BilirubinIBA 01/2022
1	Arginine (L-Arginine)FDA Link 01/2022
1	Apolipoproteins B (ApoB)IBA 01/2022
1	ApolipoproteinsIBA 01/2022
1	RNA Precursors (Precursor, mRNA)IBA 01/2022
1	Serine (L-Serine)FDA Link 01/2022
1	SodiumIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	SymportersIBA 01/2022
1	RNA Splicing FactorsIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2021
1	Bevacizumab (Avastin)FDA Link 12/2021
1	XELOXIBA 12/2021
1	PlatinumIBA 12/2021
1	CreatinineIBA 11/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Sodium-Glucose Transport ProteinsIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	benzocycloheptapyridineIBA 01/2020
1	Long Noncoding RNAIBA 01/2020
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	Methanol (Carbinol)IBA 02/2018
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2018

Therapy/Procedure

2	Percutaneous Coronary Intervention 08/2023 - 01/2022
2	Therapeutics 05/2023 - 12/2022
1	Transcranial Magnetic Stimulation 01/2023
1	Premedication 12/2021
1	Drug Therapy (Chemotherapy) 01/2018